Literature DB >> 24771883

Hypertensive Disorders of Pregnancy - A Life-Long Risk?!

C E Schausberger1, V R Jacobs1, G Bogner1, P Wolfrum-Ristau1, T Fischer1.   

Abstract

Background: Arterial hypertension is one of the most important causes of cardiovascular diseases, and the latter are responsible for almost half of the deaths in the industrialised nations. Hypertensive disorders of pregnancy constitute one of the most frequent causes of feto-maternal morbidity and mortality; on the other hand the occurrence of a hypertensive disorder of pregnancy represents a risk for the later development of hypertension and the cardiovascular risks resulting therefrom. The aim of this article is to demonstrate the association of hypertensive disorders of pregnancy with consecutive cardiovascular diseases. Materials and
Methods: Specific selective literature research.
Results: After the occurrence of a hypertensive disorder of pregnancy the relative risks for hypertension are 3.7 (2.70-5.05), for ischaemic heart disease 2.2 (1.86-2.52), for cerebral insult 1.8 (1.45-2.27) and for mortality resulting from cardiovascular causes 1.5 (1.05-2.14) and are thus significant. According to a recent study 56 % of internal specialists and 23 % of gynecologists do not know about the association of preeclampsia with ischemic heart disease, 48 % and 38 % respectively are not aware of the link with stroke and 79 % and 77 % respectively are not aware of the association with a reduced life expectancy after preeclampsia. The presence of hypertension is not known by many of the patients, merely 28-38 % receive an appropriate therapy.
Conclusion: Adequate follow-up after hypertensive disorders of pregnancy and the early recognition of and therapy for hypertension represent the cornerstones in the prevention of late cardiovascular sequelae. General practitioners, specialist for internal medicine and gynaecologists have a special responsibility with regard to the reduction of later complications.

Entities:  

Keywords:  arterial hypertension; cardiovascular risks; follow-up; hypertensive disorders of pregnancy; prevention

Year:  2013        PMID: 24771883      PMCID: PMC3859153          DOI: 10.1055/s-0032-1328172

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  39 in total

1.  Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women.

Authors:  Lori Mosca; Lawrence J Appel; Emelia J Benjamin; Kathy Berra; Nisha Chandra-Strobos; Rosalind P Fabumni; Deborah Grady; Constance K Haan; Sharonne N Hayes; Debra R Judelson; Nora L Keenan; Patrick McBride; Suzanne Oparil; Pamela Ouyang; Mehmet C Oz; Michael E Mendelsohn; Richard C Pasternak; Vivian W Pinn; Rose Marie Robertson; Karin Schenck-Gustafsson; Cathy A Sila; Sidney C Smith; George Sopko; Anne L Taylor; Brian W Walsh; Nanette K Wenger; Christine L Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-03       Impact factor: 8.311

2.  Hypertension in adults across the age spectrum: current outcomes and control in the community.

Authors:  Donald M Lloyd-Jones; Jane C Evans; Daniel Levy
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

3.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

4.  Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia.

Authors: 
Journal:  Obstet Gynecol       Date:  2011-12       Impact factor: 7.661

5.  Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure.

Authors:  James N Martin; Brad D Thigpen; Robert C Moore; Carl H Rose; Julie Cushman; Warren May
Journal:  Obstet Gynecol       Date:  2005-02       Impact factor: 7.661

6.  Long-term mortality after preeclampsia.

Authors:  Edmund F Funai; Yechiel Friedlander; Ora Paltiel; Efrat Tiram; Xiaonan Xue; Lisa Deutsch; Susan Harlap
Journal:  Epidemiology       Date:  2005-03       Impact factor: 4.822

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

8.  Effect of late-preterm birth and maternal medical conditions on newborn morbidity risk.

Authors:  Carrie K Shapiro-Mendoza; Kay M Tomashek; Milton Kotelchuck; Wanda Barfield; Angela Nannini; Judith Weiss; Eugene Declercq
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

9.  Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors.

Authors:  Elisabeth B Magnussen; Lars J Vatten; George Davey Smith; Pål R Romundstad
Journal:  Obstet Gynecol       Date:  2009-11       Impact factor: 7.661

Review 10.  Maternal preeclampsia and neonatal outcomes.

Authors:  Carl H Backes; Kara Markham; Pamela Moorehead; Leandro Cordero; Craig A Nankervis; Peter J Giannone
Journal:  J Pregnancy       Date:  2011-04-04
View more
  4 in total

Review 1.  Sex differences in stroke: the contribution of coagulation.

Authors:  Meaghan Roy-O'Reilly; Louise D McCullough
Journal:  Exp Neurol       Date:  2014-02-19       Impact factor: 5.330

2.  New Insights into the Pathogenesis of Preeclampsia - The Role of Nrf2 Activators and their Potential Therapeutic Impact.

Authors:  N Kweider; C J Wruck; W Rath
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-12       Impact factor: 2.915

3.  Efficacy and safety of combination of magnesium sulfate, phentolamine and nifedipine in treatment of patients with hypertensive disorder complicating pregnancy.

Authors:  Jinggui Zhang; Jun Li
Journal:  Exp Ther Med       Date:  2019-08-30       Impact factor: 2.447

Review 4.  Cerebrovascular disease in women.

Authors:  Aditya Kumar; Louise McCullough
Journal:  Ther Adv Neurol Disord       Date:  2021-01-27       Impact factor: 6.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.